Eterna Therapeutics
ERNA
$1.86
Share price
4.21%
Change (1 day)
-40.92%
Change (1 year)
Categories
Eterna Therapeutics (ERNA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $46.89 M
According to Eterna Therapeutics's latest financial reports the company's total liabilities are $46.89 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Eterna Therapeutics - Total liabilities on balance sheet (from 2020 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $10.17 M | 68.93% |
| 2021-12-31 | $6.02 M | 14.75% |
| 2020-12-31 | $5.24 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $57.61 B | 122,744.84% | 🇫🇷 France |
 Baxter BAX | $19.55 B | 41,591.72% | 🇺🇸 USA |
 Omeros Corporation OMER | $0.50 B | 981.10% | 🇺🇸 USA |
 Geron GERN | $0.14 B | 211.58% | 🇺🇸 USA |
 Genetic Technologies GENE | $2.49 M | -94.68% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | $35.35 B | 75,281.14% | 🇮🇱 Israel |
 Bio-Techne TECH | $0.76 B | 1,535.84% | 🇺🇸 USA |